Overview

[S,S]-Reboxetine Add-On Trial

Status:
Terminated

Trial end date:
2007-10-11

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the effectiveness of adjunctive treatment of pregabalin with [S,S]-Reboxetine against pregabalin monotherapy in patients with PHN

Phase:

Phase 2

Details

Lead Sponsor:

Pfizer

Treatments:

Pregabalin
Reboxetine